Suchergebnisse - "Chen, Guiming"

PubPharm (36)

1

Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer

enthalten in: International journal of clinical oncology | 2024

von Li, Y. | Qin, J. | Chen, G. | +2

2

Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer

enthalten in: International journal of clinical oncology | 2024

von Li, Y. | Qin, J. | Chen, G. | +2

3

Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF-mutated colorectal cancer

enthalten in: World journal of surgical oncology | 2023

von Tian, B. | Chen, G. | Shi, X. | +5

4

Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF-mutated colorectal cancer

enthalten in: World journal of surgical oncology | 2023

von Tian, B. | Chen, G. | Shi, X. | +5

5

Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF-mutated colorectal cancer

enthalten in: World journal of surgical oncology | 2023

von Tian, B. | Chen, G. | Shi, X. | +5

6

Prediction of target genes in community-acquired pneumonia based on the bioinformatics method

enthalten in: Journal of thoracic disease | 2023

von Zuo, Y. | Shen, W. | Chen, G. | +4

7

Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF mutated colorectal cancer

enthalten in: ResearchSquare.com | 2023

von Tian, B. | Chen, G. | Shi, X. | +5

8

Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation

enthalten in: Immunity | 2023

von Chen, X. | Wu, R. | Li, L. | +19

CommentIn: Immunity. 2023 Feb 14;56(2):232-234. - PMID 36792568

9

Sustained induction of IP-10 by MRP8/14 via the IFNβ-IRF7 axis in macrophages exaggerates lung injury in endotoxemic mice

enthalten in: Burns & trauma | 2023

von Wang, J. | Chen, G. | Li, L. | +6

10

Erratum : High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy

enthalten in: American journal of translational research | 2023

von Xu, C. | Yu, J. | Wu, F. | +4

ErratumFor: Am J Transl Res. 2021 May 15;13(5):4422-4436. - PMID 34150024